however, nonantimicrobial sulfonamides do not need to be avoided
Pauling This Pharmacology Consult will focus on GLP-1 receptor agonists that are currently FDA approved for weight loss, including semaglutide (Wegovy, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk), but other FDA-approved options exist, such as orlistat, naltrexone/bupropion and phentermine/topiramate
Cordyceps targets mental fatigue at the source
Tissue repair peptides injury, joints, gut BPC-157 and TB-500 are studied for tissue repair, tendon and ligament recovery, and gut health
Its important to note that while these options can help raise GLP-1 naturally, an exercise routine paired with portion control for a consistent caloric deficit is a healthier approach to weight loss that lasts over time